Costly choices for treating Wilson's disease
dc.contributor.author | Schilsky, Michael L. | en_US |
dc.contributor.author | Roberts, Eve A. | en_US |
dc.contributor.author | Hahn, Sihoun | en_US |
dc.contributor.author | Askari, Frederick | en_US |
dc.date.accessioned | 2015-04-02T15:12:36Z | |
dc.date.available | 2016-05-10T20:26:28Z | en |
dc.date.issued | 2015-04 | en_US |
dc.identifier.citation | Schilsky, Michael L.; Roberts, Eve A.; Hahn, Sihoun; Askari, Frederick (2015). "Costly choices for treating Wilson's disease." Hepatology 61(4): 1106-1108. | en_US |
dc.identifier.issn | 0270-9139 | en_US |
dc.identifier.issn | 1527-3350 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/110871 | |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.title | Costly choices for treating Wilson's disease | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/110871/1/hep27663.pdf | |
dc.identifier.doi | 10.1002/hep.27663 | en_US |
dc.identifier.source | Hepatology | en_US |
dc.identifier.citedreference | Ferenci P, Czlonkowska A, Stremmel W, Houwen R, Rosenberg W, Schilsky M, et al. EASL Clinical Practice Guidelines: Wilson's disease. J Hepatol 2012; 56: 671 ‐ 685. | en_US |
dc.identifier.citedreference | Brewer GJ, Yuzbasiyan‐Gurkan V, Johnson V, Dick RD, Wang Y. Treatment of Wilson's disease with zinc XII: dose regimen requirements. Am J Med Sci 1993; 305: 199 ‐ 202. | en_US |
dc.identifier.citedreference | Quotes for cost of medications. Available at: http://Rxpricequotes.com. Accessed October 30, 2014. | en_US |
dc.identifier.citedreference | Seoane‐Vazquez E, Rodriguez‐Monguio R, Szeinbach SL, Visaria J. Incentives for orphan drug research and development in the United States. Orphanet J Rare Dis 2008; 3: 33. | en_US |
dc.identifier.citedreference | Chandok N, Roberts EA. The trientine crisis in Canada: a call to advocacy. Can J Gastroenterol Hepatol 2014; 28: 184. | en_US |
dc.identifier.citedreference | Nocera J. The $300,000 drug. The New York Times, July 18, 2014. | en_US |
dc.identifier.citedreference | Reardon S. Regulators adopt more orphan drugs. Nature 2014; 508: 17 ‐ 18. | en_US |
dc.identifier.citedreference | Brewer GJ, Dick RD, Johnson VD, Brunberg JA, Kluin KJ, Fink JK. Treatment of Wilson's disease with zinc: XV long‐term follow‐up studies. J Lab Clin Med 1998; 132: 264 ‐ 278. | en_US |
dc.identifier.citedreference | Hoogenraad TU. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice. Brain Dev 2006; 28: 141 ‐ 146. | en_US |
dc.identifier.citedreference | Roberts EA, Schilsky ML. Diagnosis and treatment of Wilson disease: an update. Hepatology 2008; 47: 2089 ‐ 2111. | en_US |
dc.identifier.citedreference | Linn FH, Houwen RH, van Hattum J, van der Kleij S, van Erpecum KJ. Long‐term exclusive zinc monotherapy in symptomatic Wilson disease: experience in 17 patients. Hepatology 2009; 50: 1442 ‐ 1452. | en_US |
dc.identifier.citedreference | Wiggelinkhuizen M, Tilanus ME, Bollen CW, Houwen RH. Systematic review: clinical efficacy of chelator agents and zinc in the initial treatment of Wilson disease. Aliment Pharmacol Ther 2009; 29: 947 ‐ 958. | en_US |
dc.identifier.citedreference | Weiss KH, Gotthardt DN, Klemm D, Merle U, Ferenci‐Foerster D, Schaefer M, et al. Zinc monotherapy is not as effective as chelating agents in treatment of Wilson disease. Gastroenterology 2011; 140: 1189 ‐ 1198.e1. | en_US |
dc.identifier.citedreference | Medici V, Trevisan CP, D'Incà R, Barollo M, Zancan L, Fagiuoli S, et al. Diagnosis and management of Wilson's disease: results of a single center experience. J Clin Gastroenterol 2006; 40: 936 ‐ 941. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.